Page last updated: 2024-08-21

vancomycin and midazolam

vancomycin has been researched along with midazolam in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's7 (58.33)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abd Rabo Moustafa, MM; Abdelghany, TM; Eissa, IH; Elshafeey, A; Mayhoub, AS; Mohammad, H; Qassem, OA; Seleem, MN; Younis, W1
Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J1
Chen, F; Hu, L; Lan, L; Li, B; Li, J; Li, X; Ling, D; Liu, W; Liu, Y; Mao, F; Ni, S; Qiu, X; Wang, M; Wei, H; Xu, Y; Zheng, X; Zhu, J1
Servais, H; Tulkens, PM1
Belhabib, G; Combes, A; Corvol, E; Farinotti, R; Fernandez, C; Fillâtre, P; Hasni, N; Lemaitre, F; Leprince, P; Leven, C; Luyt, CE1
Abduljalil, K; Jamei, M; Johnson, TN; Pan, X; Pansari, A1
Allegaert, K; Sürmelioğlu, N; Yalcin, N1

Reviews

2 review(s) available for vancomycin and midazolam

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review.
    BMJ paediatrics open, 2022, Volume: 6, Issue:1

    Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Infant; Infant, Newborn; Midazolam; Morphine; Vancomycin

2022

Trials

1 trial(s) available for vancomycin and midazolam

ArticleYear
Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
    Clinical pharmacokinetics, 2020, Volume: 59, Issue:4

    Topics: Administration, Intravenous; Administration, Oral; Alfentanil; Anti-Bacterial Agents; Caffeine; Computer Simulation; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Female; Gentamicins; Gestational Age; Humans; Hypnotics and Sedatives; Ibuprofen; Infant, Newborn; Kidney; Liver; Male; Metabolic Clearance Rate; Midazolam; Models, Biological; Narcotics; Predictive Value of Tests; Premature Birth; Vancomycin

2020

Other Studies

9 other study(ies) available for vancomycin and midazolam

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
    European journal of medicinal chemistry, 2017, Apr-21, Volume: 130

    Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Carbanilides; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance

2017
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
    Journal of medicinal chemistry, 2018, 01-11, Volume: 61, Issue:1

    Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water

2018
Novel Staphyloxanthin Inhibitors with Improved Potency against Multidrug Resistant
    ACS medicinal chemistry letters, 2018, Mar-08, Volume: 9, Issue:3

    Topics:

2018
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:9

    Topics: Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Incompatibility; Drug Stability; Drug Therapy, Combination; Humans; Infusions, Intravenous; Midazolam; Nicardipine; Pneumonia, Bacterial; Propofol; Temperature; Vancomycin

2001
Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.
    Critical care (London, England), 2015, Feb-12, Volume: 19

    Topics: Anti-Infective Agents; Blood; Critical Illness; Cyclosporine; Drug Monitoring; Extracorporeal Membrane Oxygenation; Humans; Hypnotics and Sedatives; Midazolam; Models, Biological; Polyvinyl Chloride; Propofol; Vancomycin

2015